Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05735561
Other study ID # 2023-006
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 15, 2023
Est. completion date August 31, 2023

Study information

Verified date September 2023
Source Fraser Orthopaedic Research Society
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.


Description:

The incidence of proximal humerus fractures continues to increase and is among one of the more common fractures seen in the adult population. Proximal humerus fracture dislocations, however, are less common. Despite the decreased prevalence, fracture dislocations have unique challenges with respect to obtaining an anatomical reduction and more frequently involve an open surgical reduction. In addition, depending on other fracture characteristics, there are various treatment options for the fracture itself. While fracture dislocations ultimately lead to increased AVN and revision surgery, further discussion surrounding the direction of dislocation and how it may influence overall outcomes has not been addressed in the previous literature. The study design utilizes a retrospective cohort from the last ten years, by asking patients who have had a previously surgically treated proximal humerus fracture dislocations to come back to the surgeon's private clinic to complete a single visit assessment. During this assessment the consenting participant will receive x-rays and complete patient reported outcome measures. In conjunction, these will be utilized to assess overall function and the existence of avascular necrosis.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date August 31, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients 18 years of age or older - Patients who underwent operative fixation of proximal humerus fracture dislocation at Royal Columbian Hospital between January 2011 and July 2021 - Willing and able to consent and complete patient reported outcome measures - Willing and able to follow the protocol and attend a follow-up visit - Able to read and understand English or have an interpreter available Exclusion Criteria: - Skeletally immature patients - Patient with pathological fractures - Patients who have had previous operative fixation of proximal humerus - Patients treated non-operatively - patients presenting outside of the study duration window - Patients treated by a non-participating surgeon - Deceased patients - Patients unable to complete patient reported outcome measures - Patients declining to come back to the clinic for updated x-rays - Dementia - Incarceration

Study Design


Intervention

Diagnostic Test:
X-Ray
Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.

Locations

Country Name City State
Canada Royal Columbian Hospital/Fraser Health Authority New Westminster British Columbia

Sponsors (1)

Lead Sponsor Collaborator
Fraser Orthopaedic Research Society

Country where clinical trial is conducted

Canada, 

References & Publications (6)

Boesmueller S, Wech M, Gregori M, Domaszewski F, Bukaty A, Fialka C, Albrecht C. Risk factors for humeral head necrosis and non-union after plating in proximal humeral fractures. Injury. 2016 Feb;47(2):350-5. doi: 10.1016/j.injury.2015.10.001. Epub 2015 Oct 22. — View Citation

Cruess RL, Blennerhassett J, MacDonald FR, MacLean LD, Dossetor J. Aseptic necrosis following renal transplantation. J Bone Joint Surg Am. 1968 Dec;50(8):1577-90. No abstract available. — View Citation

Greiner S, Kaab MJ, Haas NP, Bail HJ. Humeral head necrosis rate at mid-term follow-up after open reduction and angular stable plate fixation for proximal humeral fractures. Injury. 2009 Feb;40(2):186-91. doi: 10.1016/j.injury.2008.05.030. Epub 2008 Dec 18. — View Citation

Hertel R, Hempfing A, Stiehler M, Leunig M. Predictors of humeral head ischemia after intracapsular fracture of the proximal humerus. J Shoulder Elbow Surg. 2004 Jul-Aug;13(4):427-33. doi: 10.1016/j.jse.2004.01.034. — View Citation

Miltenberg B, Masood R, Katsiaunis A, Moverman MA, Puzzitiello RN, Pagani NR, Menendez ME, Salzler MJ, Drager J. Fracture dislocations of the proximal humerus treated with open reduction and internal fixation: a systematic review. J Shoulder Elbow Surg. 2022 Oct;31(10):e480-e489. doi: 10.1016/j.jse.2022.04.018. Epub 2022 May 20. — View Citation

Schumaier A, Grawe B. Proximal Humerus Fractures: Evaluation and Management in the Elderly Patient. Geriatr Orthop Surg Rehabil. 2018 Jan 25;9:2151458517750516. doi: 10.1177/2151458517750516. eCollection 2018. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rates of Avascular Necrosis The presence and advancement of avascular necrosis (as classified by the Cruess Classification System) and as assessed on radiographs. At least 2 years post fracture fixation
Primary Direction of the Humeral Fracture Dislocation As characterized by the direction of the humeral head in relation to the glenoid, based on AP, Lateral, or Axillary x-ray views. At least 2 years post fracture fixation
Secondary DASH (functional outcome) Asking participants to complete the Disabilities of the Arm, Shoulder, and Hand outcome measure as a way of assessing function. At least 2 years post fracture fixation
Secondary Constant Score (functional outcome) Asking participants to complete the Constant Score patient reported outcome measure as a way of assessing participant function. At least 2 years post fracture fixation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03312465 - Anatomical Shoulder Domelock System Study
Completed NCT02139345 - TC-A Registration Study N/A
Completed NCT03540030 - Opioid-Free Shoulder Arthroplasty Phase 4
Completed NCT01285843 - Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component N/A
Completed NCT00750984 - A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing N/A
Active, not recruiting NCT00175487 - Comparison of Hip Resurfacing to Large Femoral Head Total Hip Arthroplasty N/A
Terminated NCT00872547 - Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement Phase 4
Completed NCT00603395 - A Prospective Clinical Study On A Total Hip Resurfacing System N/A
Recruiting NCT02503891 - AL-2 MP-1 (Polyimide) Acetabular Liner N/A
Completed NCT03666637 - Femoral Neck Fracture in Adult and Avascular Necrosis and Nonunion
Active, not recruiting NCT03343171 - Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
Enrolling by invitation NCT05067543 - Perform Humeral System Study
Recruiting NCT05002335 - Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
Active, not recruiting NCT03423953 - Comprehensive Nano - Post Market Clinical Follow-Up Study
Active, not recruiting NCT05049993 - Pyrocarbon Clinical Follow-up Study
Completed NCT02162186 - Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
Active, not recruiting NCT01700543 - Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
Active, not recruiting NCT02199600 - The Medacta International GMK Sphere Post-Marketing Surveillance Study N/A
Not yet recruiting NCT01437124 - Metal Ions in Ceramic on Metal Total Hip Arthroplasty N/A
Terminated NCT00764959 - Retrospective Study of the Linear™ Hip Phase 4